Litigation

Recent Posts

10th Circuit Majority Says Infuse Off-Label Claims Are Preempted By Congress
Posted on 21 Apr 2015 by Tom Moylan

DENVER — (Mealey’s) In a 2-1 decision, a panel of the 10th Circuit U.S. Court of Appeals on April 21 affirmed that a plaintiff’s claim alleging off-label promotion and use of Medtronic Inc.’s Infuse bone graft system is preempted... Read More

Stryker Subsidiary, Ex-CEO Plead Guilty, Pay $79 Million For Illegal Device Marketing
Posted on 9 Dec 2014 by Tom Moylan

NEWARK, N.J. — (Mealey’s) Stryker Corp. subsidiary OtisMed Corp. and the former OtisMed chief executive officer on Dec. 8 pleaded guilty to marketing the unapproved OtisKnee Orthopedic Cutting Guide medical device after the Food and Drug Administration... Read More

Ballard Spahr LLP: Pharmaceutical Companies Get Off-Label Marketing Victory
Posted on 18 Aug 2015 by Ballard Spahr LLP

. . . A federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not misleading. This ruling, while not precedential, alters the... Read More

Lawsuit Alleges Defective Zimmer Artificial Hip Has Caused Extreme Pain, Hardship
Posted on 27 May 2010 by LexisNexis Litigation Resource Community Staff

NASHVILLE, Tenn. - Mark P. Chalos from the Nashville office of the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein LLP , announced that on May 20, Walter Thomas filed a lawsuit in federal court in Nashville against Zimmer Inc... Read More

Durom Cup Lawsuits Filed Against Zimmer Allege Pain, Injuries From Artificial Hip
Posted on 23 Jul 2010 by LexisNexis Litigation Resource Community Staff

LOS ANGELES - The national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP recently announced several lawsuit filings against Zimmer Inc., the nation's largest producer of orthopedic devices, over the allegedly defective hip implant... Read More